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Abstract
Objective: To describe the development of weCope, a Portuguese mobile app for people with schizophrenia. Methods: The development of weCope followed 
4 stages: I-102 people with psychotic disorders completed an online questionnaire; II-a multidisciplinary focus group was conducted among five mental 
health professionals; III-we developed the app; IV-9 participants used weCope during 8 weeks to assess its efficiency. Results: weCope targets coping with 
voices, problem solving, goals setting and stress management, and results indicated that: weCope improved symptoms, sense of recovery and personal and 
social functioning; 59% of the participants were willing to download an application for illness self-management; professionals revealed some concerns about 
mHealth but enhanced the high importance to develop these apps; usability testing revealed that 89% considered weCope useful for illness self-management. 
However, the more years with mental illness, the less importance is given to a mobile application for this purpose. Discussion: weCope was developed through 
a comprehensive development process and may contribute to a subjective perception of the patient’s better well-being and health condition.
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Introduction
Schizophrenia is the most common severe mental illness, with 
a reported median incidence of 15.2 per 100,000 persons and a 
pooled lifetime prevalence of 0.40%1. It is a chronic neuropsychiatric 
disorder among the world’s top ten causes of long-term disability2, 
characterized by specific symptoms such as delusions, hallucinations, 
or disorganized speech that at least one must be present for not 
less than one month according to DSM-52,3. This disorder has a 
negative functional impact in many life domains of individuals with 
schizophrenia, including self-care impairment, illness management, 
social and interpersonal functioning, among others4. 
Currently, technology has great potential to promote the quality 
and effectiveness of mental health services5-8. However, there is a lack 
of scientific evidence and, consequently, an absence of guidelines 
about the incorporation of these new trends in services that treat 
individuals with mental health disorders9. Nevertheless, interventions 
based on new technologies are emerging and attracting the attention 
of researchers and enthusiasts in this area10. Mobile interventions 
are influencing psychologic approaches, they are even more 
sophisticated, offering therapeutic value for people who do not have 
access to it, and increasing their effectiveness for people who have 
face-to-face treatment11,12. Due their increased use, efforts towards 
the assessment of these devices and platforms in individuals with 
psychotic disorders are considerably growing13,14. 
The new technological approaches led to Mobile Health (mHealth) 
creation concept15. Although there is no standard definition for 
the term, mHealth refers to the use of mobile communication 
technologies in order to promote health through evidence-supported 
interventions16,17. Regarding mHealth applications, they include the 
use of mobile devices in collecting community and clinical health 
data, delivery of healthcare information to practitioners, researchers, 
and patients, real-time monitoring of patient vital signs, and direct 
care provision18. 
The transition of these tools to the mental health field was 
delayed and its potential to improve the lives of people with mental 
health problems may be jeopardize by not considering some of its 
limitations19. 
This study aims to describe the 4 stages that led to the 
development of weCope, a mobile application for illness self-
management in schizophrenia. All stages of the project were 
conducted with individuals receiving psychosocial rehabilitation 
services and mental health professionals with experience in this 
area. Ethical approval was sought and granted during all stages, that 
we present separately in order to better describe the process of app’s 
development and its preliminary results. 
Methods
Some authors have already proposed methodologies for developing 
and evaluating mobile health apps20,21, this paper follows the 
methodology used by Ben-Zeev et al.22, which is a staged approach 
that could led to the development of mobile apps for self-management 
in schizophrenia. 
Stage I: Users’ perspectives about mobile applications
Based on the state of the art on understanding the capacities, needs, 
and wants of end mHealth users, an online questionnaire was 
developed and applied to a sample of 102 persons with psychotic 
disorders (63 men, Mage = 42 years, age range: 22-66 years), mental 
health services users’. The questionnaire had 32 questions and was 
structured in three groups: sociodemographic data, technologies’ 
use patterns of the participants, and participant’s opinion about the 
development of a mobile application for support their mental illness’ 
management. Participants were also asked to rate some requirements’ 
importance related with the application development and its features, 
using a five-point Likert scale (ranging from 1 for not important at all 
to 5 for most important). An email was send to several rehabilitation 
services in Portugal, especially FNERDM (national organization that 
gathers 21 mental health institutions) and Centro Hospitalar São João, 
introducing the study with a link to the questionnaire posted online 
using Google Docs. We asked these institutions, after they had ethical 
authorisation, to send to their patients the questionnaire and to invite 
them to participate. Thus, the 102 participants do not have direct 
contact with researchers and fulfilled anonymously the questionnaire. 
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Stage II: Clinicians’ perspectives about mobile 
applications
A multidisciplinary Focus Group was conducted among five clinicians 
with different experience on schizophrenia treatment representing 
a range of service models (e.g., psychiatric hospitals, community-
based treatment). Participants were recruited by an intentional 
sample among rehabilitation psychosocial practitioners. Contacts 
were conducted by email address to five institutions where they were 
performing labour activities, inviting them to collaborate, being one 
from each institution. A semi-structured script was developed based 
on literature and the concordance between coders was registered 
and the liability calculated by Cohen’s Kappa, obtaining a score of 
0.951. Data were categorized and interpreted based on the literature.
Stage III: Mobile application prototype
A multidisciplinary team composed by engineers and mental health 
professionals was assembled to design the weCope prototype, 
considering users and professionals’ perspectives. Additionally, 
services users were consulted throughout the development process. 
The weCope app includes four modules (Figure 1): symptom 
monitoring, problem-solving, anxiety management and goal setting, 
allowing also the contact with therapists in crisis situations. 
The symptom monitoring module share one of the goals of 
Cognitive Behavioural Therapy (the conceptual framework for the 
intervention) including modifying patients’ distorted beliefs about 
delusions and hallucinations. Thus, the main objective is to monitor 
the frequency, intensity and duration of psychotic symptoms, 
their triggering events and the conditions that maintain them 
(Figure 2). The problem solving module aims to identify and modify 
the maladaptive strategies to develop more helpful alternatives, and 
the user must identify the problem and describe it, presenting two 
possible solutions and selecting his preferred one (Figure 3). The 
anxiety management module purposes the reduction of factors such 
stress for a better control of the pathology and its symptoms – the user 
can explore different types of relaxation, such Jacobson Technique. 
In goal setting module, the user has to define the goal, deadlines, 
and the support that he will require, so he can have an attitude of 
empowerment in their recovery.
Stage IV: weCope efficacy and usability
To test the app, 9 participants with a mean age of 38 years (±9.701), 
being 78% men, and with mean clinical follow-up time of 10 years 
were invited. These participants owned a smartphone and were willing 
to participate in this study. They were from ANARP, a Portuguese 
community rehabilitation centre, being a non-probabilistic sampling 
method used for a sample selected for convenience.
They use the app during 8 weeks and data collection was carried 
out in two moments (before and after the application use), using six 
evaluation instruments: Recovery Assessment Scale23, Empowerment 
Scale24, General Self-Efficacy Scale25, Social Support Satisfaction 
Scale26, Personal and Social Performance Scale27 and Positive and 
Negative Syndrome Scale28. A usability brief questionnaire was also 
applied, asking participants their ability to use de app, satisfaction, 
difficulties, etc.
The use of the app was free, based on the need of each user, and 
the usage data was guaranteed through an algorithm created that 
registers them on the server and allows to be consulted. It should 
be noted that if the medication of any of the participants changed, 
the case manager would be responsible for communicating that to 
the researcher.
Results
Regarding survey results, 78% of the participants have mobile 
phones, of which 34% were smartphones, and 59% of the participants 
were willing to download an app for illness self-management. 
Figure 1. weCOPE main menu.
Figure 2. Symptom monitoring module example.
Figure 3. Problem solving module example.
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The importance given to self-managing their mental health condition 
was high: 51% said that it was essential and 26% very important. 
However, the more years with mental illness, the less importance 
is given to a mobile application for this purpose [r(100) = -.244, 
p < 0.05] and the older the individuals, more difficulties in using 
these kind of technologies [r(100) = .209, p < 0.05]. More results are 
presented in Simões de Almeida et al.29. These results were used in 
stage III to develop weCope app.
Professionals recognized advantages in the use of mobile 
applications for therapeutic purposes, but also acknowledged some 
issues. Five categories were identified: participants’ overview on the 
use of mobile applications in mental health intervention, participants’ 
experience in technology-based interventions, adherence to the 
mobile application in schizophrenia, professionals’ concerns and 
doubts related with an app for schizophrenia and potential features 
to consider in app development. As added value, the possibility of 
using messages or another form of notification to remind patients of 
appointments and medication, to define therapeutic tasks for users 
with greater resistance to adhere to activities in hospital contexts 
complementary to working hours. Despite motivation and interest, 
these health professionals reinforced the need for professional 
supervision, privacy and the need to take into account a possible 
cognitive deterioration. These results were used in next stage to 
develop weCope app.
Regarding intervention results (Table 1), Recovery Assessment 
Scale total score presents significant results and the mean also 
increased. Empowerment Scale also presents significant results and 
the mean also increased. Social Support Satisfaction Scale presented 
statistically significant values only in subscales “intimacy” and 
“satisfaction with family”, and regarding the average, it increased 
in all subscales, excepting the subscale “social activities”. General 
Self-Efficacy Scale total score showed significant results and the 
mean also increased. Regarding Positive and Negative Syndromes 
Scale we found statistically significant values only in the general 
psychopathology subscale, and the average decreased in all subscales. 
The total score of the scale do not present significant results, but the 
mean also decreased. Finally, in Personal and Social Performance 
we found significant results on the total score of the scale and the 
mean also increased. More than the averages, it is also important to 
mention individual scores; there were improvements for each subject 
in the means of all scales with an increase in all of them except for 
PANSS scale.
Concerning the usability, the majority of participants (45%) 
used the app two or three times a week and recognize the “Anxiety 
Management” and “Goal Setting” modules and the possibility to 
exchange messages with the therapist the modules being most used 
by them. The participants’ opinion about the browsing experience, 
visual aspect and learning regarding weCope is positive as can be seen 
from Table 2. Participants showed that were satisfied with the weCope 
system, considering the application useful for the management of 
the disease (89%), and 78% said they would continue to use the app.
When questioned in an open-ended question about what they 
would like to change in the application, participants said it was 
important to enable peer interaction chats (n = 4), to monitor mood 
states and other symptoms (n = 1), to use reminders for medication 
and appointments (n  = 2) and to provide videos and other type of 
psychoeducational materials (n = 2). 
Despite some concerns from professionals, our data indicate 
an interest and several reasons to engagement in these kind of 
technologies for mental health. Considering user involvement, initial 
strategies were developed to enhance app adherence however this tool 
is suitable for a specific clinical profile of the users: younger, recent 
onset of illness, better psychopathology and receiving ambulatory 
care. 
Discussion
Technologies applied to health have been evolving rapidly in recent 
years, which has stimulated the change of patients’ roles to one in 
which they are involved in their treatment, and who have the capacity 
and interest to make decisions about themselves. Smartphones are 
widely accepted and integrated in people’s daily routines making 
them a tool readily accessible every time. When designing mobile 
applications for people with schizophrenia they should be easy 
to navigate and developed with the needs, characteristics and 
preferences of final users, involving them in the whole process. In this 
study we presented the process of mobile app development in which 
service users and mental health professionals took part in every stage.
weCope targets coping with voices, problem solving, goals setting 
and stress management. Exchanging messages with the therapist 
was one of the most used modules. This suggests that the concerns 
of the professionals with privacy may not be a barrier, since has the 
potential to reinforce the alliance between therapist and the patient. 
In fact, data security is the leading barrier to adopting innovative 
Table 1. Instrument scores 
Scales Pre-test (±DP) Post-test (±DP) p (Wilcoxon)
Recovery Assessment Scale 89.89 (±9.253) 104.11 (±7.407) 0.008**
Empowerment Scale 71.22 (±6.379) 82.11 (±5.840) 0.017*
Social Support Satisfaction Scale 50.86 (±6.936) 56.43 (±3.737) 0.021*
General Self-Efficacy Scale 57.00 (±5.523) 76.00 (±9.000) 0.007**
Positive and Negative Syndromes Scale 47.22 (±12.76) 43.44 (±9.342) 0.062
Personal and Social Performance Scale 61.89 (±15.112) 74.78 (±8.772) 0.012**
* p < 0.05. ** p < 0.01.
Table 2. Participant’s opinions about weCope
Agreement
Variable
Disagree Neutral Agree Totally agree
N % N % N % N %
Nice and legible presentation 6 66.7 3 33.3
Properly chosen icons 1 11.1 5 55.6 3 33.3
Fast access to information 1 11.1 7 77.8 1 11.1
Easy to use comparing to others 1 11.1 3 33.3 5 55.6
Menus well organized 6 66.7 3 33.3
Easy to learn 1 11.1 6 66.7 2 22.2
Intuitive in user registration 1 11.1 7 77.8 1 11.1
Easily save records 1 11.1 8 88.9
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technologies. Also, the importance of comprehensive understanding 
of the user needs in real time, with shared-decision, is one more step 
toward personalized medicine.
Despite technological tools are not the best option for every 
person, patients at a younger age and with less time of illness will 
probably be much more benefited by a mobile application. Finally, 
it is important to not forget that American Psychiatric Association30 
recommended some caution when using apps and suggested rating 
mental health apps, to help service users and professionals to make 
the best informed decision about whether or not to use an app. World 
Health Organization proposed a mHealth Evaluation, Reporting and 
Assessment guidelines for evaluating mobile health applications20. 
Developers should integrate the following four characteristics of 
high-efficacy mental health apps: high patient engagement, simple 
user interface and experience, transdiagnostic capabilities and 
have self-monitoring features31. WeCope was designed considering 
that and was well received by the participants and demonstrated 
significant results at the level of perception of the participants’ better 
well-being and health condition. Moreover, the mobile application 
was evaluated as performing well in terms of responding to user needs 
and user experience, however conclusions have to be considered 
preliminary considering the small number of patients who used the 
tool. Being an app developed in Portuguese language, it can be used 
in different countries such are Brazil and some African countries (e.g. 
Mozambique, Angola, Cabo Verde Island, etc.). Although preliminary 
results show good efficacy of the weCope app, more robust future 
studies, with larger samples, are needed to examine whether the 
improvements persist over time. In addition, since there was no 
control group, it was not possible to determine whether the clinical 
improvements were related only to the use of weCope. 
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